SCHEMBL16308958

SCHEMBL16308958

COc1cc(C(C)C)ccc1S(=O)(=O)O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 8/20 0.47
▸ SMN1; SMN2 Q16637 2/20 0.46
▸ POLB P06746 1/20 0.46
▸ HDAC4 P56524 1/20 0.45
▸ HDAC8 Q9BY41 1/20 0.45
▸ KMT2A Q03164 2/20 0.44
▸ LMNA P02545 1/20 0.44
▸ MAPT P10636 1/20 0.44
▸ HPGD P15428 1/20 0.44
▸ ACHE P22303 2/20 0.43
▸ CA1 P00915 1/20 0.43
▸ CA2 P00918 1/20 0.43
▸ RECQL P46063 1/20 0.42
▸ NPSR1 Q6W5P4 1/20 0.42
▸ TSHR P16473 1/20 0.42
▸ TRPV4 Q9HBA0 1/20 0.41
▸ FABP3 P05413 1/20 0.41
▸ FABP4 P15090 1/20 0.41
▸ FABP5 Q01469 1/20 0.41
▸ BCHE P06276 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10880591 0.86 ALDH1A1 (0.57) ALDH1A1SMN1; SMN2POLBHDAC4HDAC8
SCHEMBL13450384 0.84 ALDH1A1 (0.48) ALDH1A1SMN1; SMN2POLBHDAC4HDAC8
SCHEMBL30184710 0.83 TRPV4 (0.62) ALDH1A1SMN1; SMN2POLBHDAC4HDAC8
SCHEMBL30392211 0.83 CA1 (0.50) ALDH1A1SMN1; SMN2POLBHDAC4HDAC8
SCHEMBL23598878 0.83 CA1 (0.50) ALDH1A1SMN1; SMN2POLBHDAC4HDAC8
SCHEMBL25045980 0.83 TRPV4 (0.62) ALDH1A1SMN1; SMN2POLBHDAC4HDAC8
SCHEMBL29397450 0.81 NFKB1 (0.60) ALDH1A1SMN1; SMN2KMT2ALMNAMAPT
SCHEMBL28709318 0.81 NFKB1 (0.60) ALDH1A1SMN1; SMN2KMT2ALMNAMAPT
SCHEMBL16259602 0.78 ALDH1A1 (0.48) ALDH1A1SMN1; SMN2POLBHDAC4HDAC8
SCHEMBL28325511 0.77 MCOLN3 (0.49) ALDH1A1SMN1; SMN2POLBKMT2ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250145637-A1 SULFONAMIDE DERIVATIVE, PREPARATION METHOD THEREFOR AND MEDICAL USE THEREOF JIANGSU HENGRUI PHARMACEUTICALS CO., LTD. (CN) 2025-05-08 — — US disclosed
EP-4385989-A1 SULFONAMIDE DERIVATIVE, PREPARATION METHOD THEREFOR AND MEDICAL USE THEREOF Jiangsu Hengrui Pharmaceuticals Co., Ltd. (CN) 2024-06-19 — — EP disclosed
CN-117597341-A Sulfonamide derivative, preparation method and application thereof in medicine 江苏恒瑞医药股份有限公司 2024-02-23 — — CN disclosed
WO-2023016484-A1 SULFONAMIDE DERIVATIVE, PREPARATION METHOD THEREFOR AND MEDICAL USE THEREOF 江苏恒瑞医药股份有限公司 2023-02-16 — — WO disclosed
WO-2023016484-A1 SULFONAMIDE DERIVATIVE, PREPARATION METHOD THEREFOR AND MEDICAL USE THEREOF 江苏恒瑞医药股份有限公司 2023-02-16 — — WO disclosed
US-20140366285-A1 COLORING COMPOSITION FOR TEXTILE PRINTING, TEXTILE PRINTING METHOD AND FABRICS FUJIFILM CORPORATION (JP) 2014-12-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250145637-A1 SULFONAMIDE DERIVATIVE, PREPARATION METHOD THEREFOR AND MEDICAL USE THEREOF SULT2A1, KAT8, TST ALDH1A1 399/4885SMN1; SMN2 4679/4885POLB 2185/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback